An NGS assay to quantify biomarkers of the host immune response in FFPE tumor samples

October 25, 2017 1 Comment 5,570 Views

OmniSeq Inc scientists have developed a next-generation sequencing assay to quantify biomarkers of the host immune response in formalin-fixed, paraffin-embedded (FFPE) tumor specimens. This assay aims to provide clinicians with a comprehensive characterization of the immunological tumor microenvironment as a ...

RNA-Seq Blog Transcriptome Research & Industry News

Tag Archives: OmniSeq Inc

An NGS assay to quantify biomarkers of the host immune response in FFPE tumor samples

Optimised RNA extraction method unlocks tough tissues for aquaculture research

dsRID – in silico identification of dsRNA regions using long-read RNA-seq data

FUN-PROSE – predicting the response of fungal genes

Unraveling the timeline of gene expression – a pseudotemporal trajectory analysis of single-cell RNA sequencing data

INVADEseq – cataloging bacterial diversity within tumor samples

RNA sequencing identifies genetic effects of traumatic brain injury using an artificial brain

Researchers develop new method to identify and remove background noise from single cell data